NCT06377631View on ClinicalTrials.gov

Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 7, 2024

Primary Completion Date

April 8, 2025

Study Completion Date

April 8, 2025

Conditions
Visceral ObesityNon-alcoholic Fatty LiverPostmenopausal
Interventions
DIETARY_SUPPLEMENT

Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

DIETARY_SUPPLEMENT

Placebo

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

Trial Locations (2)

43204

Anna Crescenti, Reus

Fundació Eurecat, Reus

All Listed Sponsors
collaborator

Centre de Diagnosi per la Imatge

UNKNOWN

collaborator

Instituto de Investigación Biomédica de Girona (IDIBGI)

UNKNOWN

collaborator

Laboratorio de Referencia de Cataluña

UNKNOWN

lead

Fundació Eurecat

OTHER

NCT06377631 - Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity | Biotech Hunter | Biotech Hunter